Bulletin
Investor Alert

New York Markets Close in:

Pfizer Inc.

NYS: PFE

GO
/marketstate/country/us

Countdown to close

PFE
/zigman2/quotes/202877789/composite

$

39.51

Change

+0.21 +0.52%

Volume

Volume 13.21m

Jun 17, 2021, 3:40 p.m.

Real time quotes

/zigman2/quotes/202877789/composite

Previous close

$ 39.30

$ 39.51

Change

+0.21 +0.52%

Day low

Day high

$39.07

$39.56

Open
Open: 39.27

52 week low

52 week high

$29.94

$43.08

Open

Market cap

$219.99B

Average volume

27.35M

P/E ratio

20.07

Rev. per Employee

$533,860

EPS

1.97

Dividend

0.39

Div yield

3.95%

Ex dividend date

5/6/21

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/pfe

MarketWatch News on PFE

  1. Pfizer Covid-19 Vaccine Could See Blockbuster Sales for Years

    10:19 a.m. Today

    - Josh Nathan-Kazis

  2. CureVac Stock Tumbles After Vaccine Failure. Why More Pain May Be Coming.

    9:31 a.m. Today

    - Josh Nathan-Kazis

  3. CureVac’s COVID vaccine candidate 47% effective, stock tanks

    7:25 a.m. Today

    - Claudia Assis

  4. CureVac tumbles 41% in premarket on COVID-19 vaccine disappointment

    6:44 a.m. Today

    - Barbara Kollmeyer

  5. Johnson & Johnson stock outperforms market despite losses on the day

    4:32 p.m. June 16, 2021

    - MarketWatch Automation

  6. Johnson & Johnson stock falls Tuesday, underperforms market

    4:32 p.m. June 15, 2021

    - MarketWatch Automation

  7. Novavax Vaccine Is Real Competition for Pfizer and Moderna

    10:59 a.m. June 15, 2021

    - Bill Alpert

  8. S&P 500, Nasdaq Hit New Records as Bond Yields Remain Contained

    4:46 p.m. June 14, 2021

    - Nicholas Jasinski

  9. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/pfe

Other News on PFE

  1. CureVac Value Halves in Reminder of Vaccine Research Risks

    12:52 p.m. Today

    - Denise Roland

  2. U.S. to invest more than $3B to boost development of COVID-19 antiviral drugs

    12:27 p.m. Today

    - Seeking Alpha

  3. Pfizer's Xeljanz shows efficacy against COVID-19 pneumonia

    11:57 a.m. Today

    - Seeking Alpha

  4. Why CureVac Stock Is Getting Crushed Today

    11:06 a.m. Today

    - Motley Fool

  5. Atea surges as COVID-19 pill attracts government attention

    11:04 a.m. Today

    - Seeking Alpha

  6. CureVac (CVAC) Plummets on Disappointing COVID-19 Vaccine Data

    10:30 a.m. Today

    - Zacks.com

  7. CVAC Stock: The Huge Covid-19 News That Has CureVac Plunging Today

    8:42 a.m. Today

    - InvestorPlace.com

  8. CureVac Shares Plunge Premarket on Disappointing Vaccine Trial

    6:44 a.m. Today

    - Peter Loftus

  9. Pfizer’s tofacitinib meets primary endpoint in Brazilian COVID-19 study

    3:00 a.m. Today

    - Seeking Alpha

  10. BioNTech CEO Sahin warns of possible COVID resurgence from Delta variant - Barron's

    12:40 a.m. Today

    - Seeking Alpha

  11. Why BioNTech Stock Was Sliding Today

    4:38 p.m. June 16, 2021

    - Motley Fool

  12. Is There Still Upside Potential for Novavax Stock?

    12:00 p.m. June 16, 2021

    - InvestorPlace.com

  13. China Steps Into Covid-19 Vaccine Void in Asia’s Developing Nations

    9:08 a.m. June 16, 2021

    - Niharika Mandhana

  14. Some Bulls Are Double Counting Cash And Earnings At Moderna

    8:43 a.m. June 16, 2021

    - Seeking Alpha

  15. It’s Time to Admit Defeat and Dump Ocugen Stock as a Covid Play

    8:13 a.m. June 16, 2021

    - InvestorPlace.com

  16. Loading more headlines...
/news/pressrelease/company/us/pfe

Press Releases on PFE

  1. Cancer Biomarkers Market To Witness Revolutionary Growth By 2027

    1:46 p.m. Today

    - Heraldkeepers

  2. Biologic Excipients Market Share Growth, Size Value, Trends, Rigonal outlook by 2028

    1:35 p.m. Today

    - Heraldkeepers

  3. E-Learning Solutions Market Alalyses Major Opportunities, Trends, Drivers and Challenges

    8:56 a.m. Today

    - Market Insight Reports

  4. Financial Leasing Services Market 2021 – Insights and Precise Outlook Analysis By 2027

    8:55 a.m. Today

    - Market Insight Reports

  5. Loading more headlines...

Rates »

Link to MarketWatch's Slice.